Voices
Jordan Ciuro: How Age Impacts Treatment Benefit in Metastatic Hormone-Sensitive Prostate Cancer
Jordan Ciuro/X

Jordan Ciuro: How Age Impacts Treatment Benefit in Metastatic Hormone-Sensitive Prostate Cancer

Jordan Ciuro, Oncologist at the Medical College of Georgia at Augusta University, shared a post on X:

“New in NEJM Evidence! Age and its Impact in mHSPC. Check out important work by Alicia Morgans and team on how age impacts treatment benefit in mHSPC.

Morgans et al.

Also just out my accompanying editorial with mentor Brad Carthon exploring what age really means for personalized prostate cancer care Editorial.”

Title: Age and Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

Authors: Alicia K. Morgans, Soumyajit Roy, Angela Y. Jia, Pedro Barata, Nicholas G. Zaorsky, Jorge A. Garcia, Jason R. Brown, Santosh Rao, Prateek Mendiratta, Andrew J. Armstrong, Maha H. Hussain, Gerhardt Attard, Nicholas D. James, Karim Fizazi, Yilun Sun, Daniel E. Spratt

Read Full Article.

Jordan Ciuro

Title: Age Matters – Personalizing Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

Authors: Jordan Ciuro, Bradley C. Carthon,

Read Full Editorial.

Jordan Ciuro: How Age Impacts Treatment Benefit in Metastatic Hormone-Sensitive Prostate Cancer

Alicia K. Morgans Andrew J. Armstrong Angela Y. Jia Bradley C. Carthon cancer Daniel E Spratt Gerhardt Attard Jason R. Brown Jordan Ciuro Jorge A Garcia Karim Fizazi Maha H. Hussain Nicholas D. James Nicholas G. Zaorsky OncoDaily Oncology Pedro Barata Prateek Mendiratta Santosh Rao Soumyajit Roy Yilun Sun